By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel's net takeaway is that UiPath's (PATH) current valuation (3.5x forward P/S, 14.5x forward P/E) is likely a ceiling rather than a floor, given the deceleration in ARR growth, competitive pressure from hyperscalers like Microsoft, and the risk of customer consolidation in favor of platform-native tools.
Risk: The single biggest risk flagged is the 'integration tax' - UiPath's reliance on legacy ERP/CRM ecosystems may lead CIOs to prioritize platform-native tools over third-party orchestration layers, consolidating AI budgets and putting pressure on UiPath's ARR growth.
Opportunity: The single biggest opportunity flagged is UiPath's ability to turn Maestro pilots into durable ARR uplift and multi-year contracts, which could re-rate the stock despite hyperscaler pressure.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
UiPath is seeing some momentum from artificial intelligence.
It has big potential opportunity in front with its agentic AI orchestration.
Meanwhile, the stock is trading at a cheap valuation.
UiPath's (NYSE: PATH) stock remains beaten down, trading more than 25% below its level at the start of the year. While the company has shown some signs of life, it has been caught in the software-as-a-service (SaaS) sell-off. UiPath is a company that specializes in automation using software bots and orchestration software for agentic AI.
The company recently reported solid fiscal first-quarter results, but the question is whether this can help the company get out of its doldrums. Let's take a closer look.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Momentum continues to build
UiPath saw some solid, albeit still muted, momentum in its first quarter. AI agentic orchestration remains a top priority, and AI products were included in 16 of its 20 largest deals in the quarter. Meanwhile, AI deals were six times larger, on average, than non-AI deals.
The company continues to do well within its existing customer base, with the company reporting a 109% dollar-based net retention rate over the past 12 months. That was an uptick from the 107% it reported in Q4. Any number over 100% indicates that existing customers are growing after a period of churn. New annual recurring revenue (ARR), meanwhile, came in at $49 million.
Overall revenue for the quarter climbed by 17% to $418.4 million, well above its guidance for revenue of $395 million to $400 million. Its ARR rose by 12% year over year to $1.9 billion. Adjusted earnings per share (EPS) jumped by 36% to $0.15.
Looking ahead, UiPath guided for second-quarter revenue in the range of $395 million to $400 million, representing 9% to 11% growth. It guided for ARR between $1.929 billion and $1.934 billion.
For the full year, it upped its revenue forecast to be between $1.776 billion and $1.781 billion and its ARR forecast to be between $2.058 billion and $2.063 billion. That's up from a prior outlook of revenue of $1.754 billion to $1.759 billion, with ARR of between $2.051 billion and $2.056 billion.
Is the stock a buy?
While UiPath turned in a solid quarter, it issued conservative Q2 guidance, in part due to some currency headwinds. While the stock is cheap, trading at a forward price-to-sales ratio of 3.5 and a forward P/E of around 14.5, the company needs to see more meaningful ARR growth acceleration for the stock to really work from here.
Agentic AI is still in the very early stages of taking off, and, based on commentary from the AI infrastructure names, this is a real, emerging trend. UiPath's Maestro platform has a big opportunity to be an important AI orchestration tool, and it's already integrated with major platforms such as Alphabet's Google Cloud, Microsoft, and Salesforce. Meanwhile, it's also enabled its platform to handle coding agents, helping provide governance orchestration.
This is a big potential growth driver, but UiPath is not the only player chasing this opportunity, and there is no guarantee it will get its fair share of this emerging market. The stock is speculative, but its low valuation makes it an interesting investment.
Before you buy stock in UiPath, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UiPath wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $449,393! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,366,006!
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 3, 2026. *
Geoffrey Seiler has positions in Alphabet, Salesforce, and UiPath. The Motley Fool has positions in and recommends Alphabet, Microsoft, Salesforce, and UiPath. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"UiPath looks cheap on multiple metrics, but until ARR growth accelerates and profitability/monetization from Maestro proves durable, the upside is not compelling."
UiPath's quarterly numbers show resilience but not a clear acceleration in core ARR, and the AI-driven growth narrative remains unproven as a durable revenue driver. The stock trades at ~3.5x forward revenue and ~14.5x forward earnings, which already prices in sizeable optionality from Maestro and agentic orchestration, yet the Q2 guide (9-11% rev growth) and modest ARR annual uplift imply limited near-term catalysts. Currency headwinds and software-economy softness could weigh on growth, while competition narrows the moat for enterprise automation. A cautious stance hinges on whether Maestro becomes a meaningful monetization engine or stays a beta-like platform.
The bear case: if Maestro/agentic orchestration fails to scale monetically or if enterprise AI budgets falter, the stock's cheap multiple won't rescue downside; ongoing revenue momentum is still modest, and macro SaaS risk could trigger further multiple compression.
"UiPath's decelerating ARR growth signals that its automation dominance is under siege by platform-native competitors, rendering its current 'cheap' valuation misleading."
UiPath (PATH) is currently a classic 'value trap' candidate. While a forward P/E of 14.5x looks attractive, the deceleration in ARR growth—from double digits to a projected 9-11% in Q2—is the real story. The article highlights AI momentum, but fails to address the competitive moat degradation; UiPath is increasingly squeezed between hyperscalers like Microsoft (Power Automate) and pure-play AI agent startups. A 109% net retention rate is decent, but insufficient to justify a premium if the top-line growth continues to compress. Without a clear path to re-accelerating ARR above 15%, the current valuation multiple is likely a ceiling, not a floor, for the stock.
If UiPath successfully pivots to becoming the 'control plane' for enterprise agentic AI, its low valuation provides a massive margin of safety for a potential acquisition target by a major cloud provider.
"UiPath's valuation is cheap only if Q2+ guidance proves conservative and agentic AI drives ARR acceleration above 15% YoY; the Q2 guide of 9-11% growth suggests neither is happening yet."
UiPath's Q1 beat and 109% NRR are real positives, but the article conflates two separate narratives: execution (17% revenue growth, solid retention) and speculation (agentic AI upside). The Q2 guidance of 9-11% growth is a deceleration, not acceleration—the article's headline overstates momentum. At 3.5x forward P/S and 14.5x forward P/E, the valuation looks cheap only if you believe agentic AI adoption accelerates meaningfully. The 16-of-20 largest deals including AI is encouraging but doesn't prove TAM expansion—it may reflect customer consolidation or deal mix shift. Currency headwinds are mentioned but not quantified. Most critically: UiPath competes against better-capitalized players (Microsoft, Salesforce, Google) in orchestration. No moat is evident.
If agentic AI adoption stalls or gets commoditized by hyperscalers bundling orchestration into their platforms, UiPath's TAM stays flat and the stock re-rates to 2x P/S on slower growth—downside to $8-10. The article assumes PATH wins share in an emerging market; that's not guaranteed.
"PATH's low-teens ARR trajectory and conservative guidance show AI momentum is not yet material enough to overcome competitive and macro headwinds."
PATH's Q1 results show 17% revenue growth to $418M and 12% ARR expansion to $1.9B, with AI products in 16 of 20 large deals. Yet Q2 guidance of just 9-11% growth and full-year ARR forecast implying only low-teens expansion reveal no acceleration. At 3.5x forward sales the multiple appears cheap, but this pricing already embeds skepticism that Maestro orchestration can outpace Microsoft, Salesforce, and emerging rivals in a nascent agentic market where partners often become competitors.
Agentic AI remains so early that PATH could still capture disproportionate share through its existing customer base and governance features, driving ARR reacceleration that justifies a re-rating well above current levels.
"Maestro monetization is the real swing factor; moat erosion is less decisive than whether PATH can monetize Maestro."
Gemini, moat concerns are valid, but the bigger hinge is Maestro monetization. If PATH can turn Maestro pilots into durable ARR uplift and multi-year contracts, the stock can re-rate even amid hyperscaler pressure. Without meaningful monetization milestones, PATH risks a multiple squeeze as 9-11% growth looks baked, and 109% NRR may prove insufficient. So the question isn't whether PATH can defend its moat, but whether Maestro can become a true revenue driver.
"UiPath faces an existential threat from cloud-native platform bundling that makes their orchestration layer redundant for enterprise CIOs."
ChatGPT and Gemini are obsessing over Maestro, but you are all ignoring the 'integration tax.' UiPath’s reliance on legacy ERP/CRM ecosystems is a massive friction point compared to Microsoft’s native Power Automate stack. If enterprise AI budgets consolidate, CIOs will prioritize platform-native tools over third-party orchestration layers to avoid fragmented tech debt. UiPath isn't just fighting for market share; they are fighting against the natural gravitational pull of cloud-native bundling, which makes their ARR growth ceiling look even lower.
"Integration tax is real, but PATH's defensibility hinges on governance/compliance moat, not native bundling—and that moat erodes if hyperscalers add audit trails to their orchestration layers."
Gemini's 'integration tax' argument is the sharpest risk flagged so far, but it assumes CIOs optimize for platform consolidation over best-of-breed functionality. Enterprise reality is messier: legacy ERP/CRM stacks are fragmented, and orchestration often sits *above* those systems. UiPath's moat isn't native integration—it's governance and audit trails for regulated workflows. That said, if Microsoft bundles Maestro-like capabilities into Power Platform at zero marginal cost, PATH's pricing power evaporates fast. The real question: does PATH's existing customer footprint (1.9B ARR) provide enough stickiness to survive commoditization, or is it already too late?
"Governance moat is vulnerable to hyperscaler bundling, accelerating integration tax effects on ARR."
Claude overestimates stickiness from governance features, as Microsoft can integrate audit and compliance directly into Power Automate without extra cost. This amplifies Gemini's integration tax risk, where CIOs favor unified platforms over third-party layers. With Q2 growth already slowing to 9-11%, any customer shift would force further multiple compression at 3.5x sales, regardless of 109% NRR.
The panel's net takeaway is that UiPath's (PATH) current valuation (3.5x forward P/S, 14.5x forward P/E) is likely a ceiling rather than a floor, given the deceleration in ARR growth, competitive pressure from hyperscalers like Microsoft, and the risk of customer consolidation in favor of platform-native tools.
The single biggest opportunity flagged is UiPath's ability to turn Maestro pilots into durable ARR uplift and multi-year contracts, which could re-rate the stock despite hyperscaler pressure.
The single biggest risk flagged is the 'integration tax' - UiPath's reliance on legacy ERP/CRM ecosystems may lead CIOs to prioritize platform-native tools over third-party orchestration layers, consolidating AI budgets and putting pressure on UiPath's ARR growth.